Infection  >>  cyclosporin A microemulsion  >>  Phase 4
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
cyclosporin A microemulsion / Generic mfg.
NCT00260208 / 2005-001221-28: Liver Fibrosis in Patients Transplanted for Hepatitis C Receiving Either Cyclosporine Microemulsion or Tacrolimus

Terminated
4
361
US, Europe
Cyclosporine A, Neoral, Tacrolimus
Novartis Pharmaceuticals
Liver Transplant, Hepatitis C
09/10
 
NCT00938860 / 2009-010806-12: Sustained Virological Response (SVR) to Antiviral Treatment of Liver Transplant Recipients With Recurrent Hepatitis C

Completed
4
92
US, Canada, Europe, RoW
cyclosporin (Neoral), tacrolimus (Prograf)
Novartis Pharmaceuticals
Hepatitis C, Liver Transplantation
05/13
05/13
PHI-IMD, NCT00979706: Immune-based Therapy Pilot Study for the Treatment of Primary HIV Infection ().

Completed
4
22
Europe
HAART, Viread, Epivir, Kaletra, HAART + Immunotherapy, Cyclosporine A, GM-CSF, Peg-IFN, Interleukin-2
Juan A. Arnaiz
HIV
11/14
11/14
EVERCMV, NCT02328963 / 2013-003195-12: Proportion of CMV Seropositive Kidney Transplant Recipients Who Will Develop a CMV Infection When Treated With an Immunosuppressive Regimen Including Everolimus and Reduced Dose of Cyclosporine Versus an Immunosuppressive Regimen With Mycophenolic Acid and Standard Dose of Cyclosporine A

Completed
4
186
Europe
Everolimus, mycophenolic acid
University Hospital, Bordeaux, Novartis
Transplantation Infection, Cytomegalovirus Infection
10/18
10/18

Download Options